Suppr超能文献

DRP1 介导线粒体裂变促进 IR-783 诱导的人乳腺癌细胞凋亡。

Dynamin-related protein 1-mediated mitochondrial fission contributes to IR-783-induced apoptosis in human breast cancer cells.

机构信息

Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, China.

出版信息

J Cell Mol Med. 2018 Sep;22(9):4474-4485. doi: 10.1111/jcmm.13749. Epub 2018 Jul 11.

Abstract

IR-783 is a kind of heptamethine cyanine dye that exhibits imaging, cancer targeting and anticancer properties. A previous study reported that its imaging and targeting properties were related to mitochondria. However, the molecular mechanism behind the anticancer activity of IR-783 has not been well demonstrated. In this study, we showed that IR-783 inhibits cell viability and induces mitochondrial apoptosis in human breast cancer cells. Exposure of MDA-MB-231 cells to IR-783 resulted in the loss of mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) depletion, mitochondrial permeability transition pore (mPTP) opening and cytochrome c (Cyto C) release. Furthermore, we found that IR-783 induced dynamin-related protein 1 (Drp1) translocation from the cytosol to the mitochondria, increased the expression of mitochondrial fission proteins mitochondrial fission factor (MFF) and fission-1 (Fis1), and decreased the expression of mitochondrial fusion proteins mitofusin1 (Mfn1) and optic atrophy 1 (OPA1). Moreover, knockdown of Drp1 markedly blocked IR-783-mediated mitochondrial fission, loss of MMP, ATP depletion, mPTP opening and apoptosis. Our in vivo study confirmed that IR-783 markedly inhibited tumour growth and induced apoptosis in an MDA-MB-231 xenograft model in association with the mitochondrial translocation of Drp1. Taken together, these findings suggest that IR-783 induces apoptosis in human breast cancer cells by increasing Drp1-mediated mitochondrial fission. Our study uncovered the molecular mechanism of the anti-breast cancer effects of IR-783 and provided novel perspectives for the application of IR-783 in the treatment of breast cancer.

摘要

IR-783 是一种七甲川氰染料,具有成像、癌症靶向和抗癌特性。先前的研究报告称,其成像和靶向特性与线粒体有关。然而,IR-783 抗癌活性的分子机制尚未得到很好的证明。在这项研究中,我们表明 IR-783 抑制人乳腺癌细胞的活力并诱导线粒体凋亡。IR-783 暴露于 MDA-MB-231 细胞中导致线粒体膜电位(MMP)丧失、三磷酸腺苷(ATP)耗竭、线粒体通透性转换孔(mPTP)开放和细胞色素 c(Cyto C)释放。此外,我们发现 IR-783 诱导动力相关蛋白 1(Drp1)从细胞质易位到线粒体,增加线粒体分裂蛋白线粒体分裂因子(MFF)和分裂-1(Fis1)的表达,并降低线粒体融合蛋白线粒体融合蛋白 1(Mfn1)和视神经萎缩 1(OPA1)的表达。此外,Drp1 的敲低显着阻断了 IR-783 介导的线粒体分裂、MMP 丧失、ATP 耗竭、mPTP 开放和凋亡。我们的体内研究证实,IR-783 与 Drp1 在线粒体易位相关,显着抑制 MDA-MB-231 异种移植模型中的肿瘤生长并诱导凋亡。总之,这些发现表明,IR-783 通过增加 Drp1 介导的线粒体分裂诱导人乳腺癌细胞凋亡。我们的研究揭示了 IR-783 抗乳腺癌作用的分子机制,并为 IR-783 在乳腺癌治疗中的应用提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/6111821/5b89184b290f/JCMM-22-4474-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验